Sign in

CIK 0001770121 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company

Sana Biotechnology, Inc.

Sign in to watch
Ticker
SANA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
831381173
Phone
(206) 701-7914
Business address
188 EAST BLAINE STREET, SUITE 350, SEATTLE, WA
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 65 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2023-05-26 Flagship Ventures Fund V General Partner LLC 10% owner Sale −72,670 $6.23 $452K 11,101,994
2023-05-26 Flagship Ventures Fund V General Partner LLC 10% owner Sale −9,330 $6.23 $58K 1,425,334
2023-05-25 Flagship Ventures Fund V General Partner LLC 10% owner Sale −102,245 $6.35 $649K 11,174,664
2023-05-25 Flagship Ventures Fund V General Partner LLC 10% owner Sale −13,127 $6.35 $83K 1,434,664
2023-05-24 Flagship Ventures Fund V General Partner LLC 10% owner Sale −308,290 $6.57 $2.0M 11,276,909
2023-05-24 Flagship Ventures Fund V General Partner LLC 10% owner Sale −39,580 $6.57 $260K 1,447,791
2023-04-10 WILLIAMS DOUGLAS E EVP & President, R&D Grant or award · Stock Option (Right to Buy) +1,100,000 1,100,000
2023-04-05 Wilderotter Mary Agnes Director Grant or award +2,314 2,314
2023-04-05 Bishop Hans Edgar Director Grant or award +7,716 5,760,888
2023-03-02 Hordo Christian EVP, Chief Business Officer Grant or award · Stock Options (Right to Buy) +185,000 185,000
2023-03-02 Harr Steve President & CEO Grant or award · Stock Options (Right to Buy) +650,000 650,000
2023-03-02 Cassidy Bernard J EVP & General Counsel Grant or award · Stock Options (Right to Buy) +140,000 140,000

Page 9 of 9 · 172 trades